GERN FY 2016 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-83.1% YoY

Gross Profit

-$9M-138.5% margin

Operating Income

-$31M-497.3% margin

Net Income

-$30M-479.3% margin

EPS (Diluted)

$-0.19

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$130M

Total Liabilities

$8M

Stockholders' Equity

$122M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$36M	-83.1%
Gross Profit	-$9M	$27M	-131.8%
Operating Income	-$31M	-$559,000	-5382.3%
Net Income	-$30M	$46,000	-64310.9%